000			01139nam a2200145Ia 4500
008			220515s9999||||xx |||||||||||||| ||und||
050			_aART WC 503.I66 2008
110			_aInternational Partnership for Microbicides
245		4	_aThe use of antiretroviral drugs (ARVs) in microbicides and the potential for the development of drug-resistant Strains of HIV: a consensus statement by IPM and the executive committee of the IPM scientific advisory board
260			_bInternational Partnership for Microbicides _c2008
300			_a6p.
500			_aOffers a comprehensive assessment of the balance of potential risks and benefits of using antiretroviral drugs to prevent HIV transmission is a priority for those involved in HIV prevention research and examines the background and structure on issues specific to vaginal microbicides. Examines the implications of drug resistance for the therapeutic outcome on HIV- treatment and the concerns regarding a microbicides potential impact on HIV drug resistance.
650			_aAntiretroviral Agents|Acquired Immune Deficiency Syndrome Virus|HIV Prevention|Anti-Infective Agents
942			_2lcc _cBK
999			_c6668 _d6668